Vascular Risk Progression in Normal and Diabetic Control Subjects.
NCT ID: NCT00579228
Last Updated: 2023-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2007-04-25
2018-03-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women
NCT00037258
Risk Factors of Individuals With Coronary Artery Disease
NCT00260104
Epidemiology of Cardiovascular Disease in Diabetes
NCT00037297
Genetic Markers of Coronary Heart Disease in Type 2 Diabetes
NCT00078052
Diet, Genetics, and CVD Risk Factor Response in Blacks
NCT00079703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 Cardiovascular disease (CVD) in Participants without diabetes
Progression of cardiovascular disease (CVD) in participants without diabetes
No interventions assigned to this group
2 Cardiovascular disease (CVD) in participants with type 2 Diabetes
Progression of cardiovascular disease (CVD) in participants with type 2 Diabetes with good control
No interventions assigned to this group
3 Cardiovascular disease (CVD) in participants with type 1 diabetes
Progression of cardiovascular disease (CVD) in participants with type 1 diabetes with good control
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Those with Diabetes need to have the condition for at least 5 years.
* Normal controls need to have no diabetes, kidney disease, or chronic disease.
Exclusion Criteria
* Any condition that would change weight dramatically in the near future such as malabsorption, pregnancy, malignancy
* For Normal: BMI\>30, BP \> 140/90 , LDL \> 130.
* For Diabetes: BP\> 135/85, A1C\> 8%. LDL \> 100.
19 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nebraska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Larsen, MD
Role: PRINCIPAL_INVESTIGATOR
University of Nebraska
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Nebraska Medical Center
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0124-07-EP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.